Global Financial Private Client’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Global Financial Private Client's AZN Position: Q2 2025 in Review
Global Financial Private Client sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 104 shares — an estimated $15.2K sold.
Global Financial Private Client first reported a position in AZN in Q4 2019 and held it in 21 quarters. The position peaked at $335K in Q3 2024. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.
- Global Financial Private Client reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
- Global Financial Private Client sold 104 AstraZeneca shares in Q2 2025, an estimated $15.2K.
- Global Financial Private Client first reported a position in AstraZeneca in Q4 2019 and held it in 21 quarters.
- Global Financial Private Client's AstraZeneca position peaked at $335K in Q3 2024.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.
Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.